References
- Freeman C, Parish CR. Human platelet heparanase: purification, characterization and catalytic activity. Biochem J. 1998;330(3):1341–1350.
- Weiss RJ, Esko JD, Tor Y. Targeting heparin and heparan sulfate protein interactions. Org Biomol Chem. 2017;15(27):5656–5668.
- Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 1992;12(2):112–127.
- Goshen R, Hochberg AA, Korner G, et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol Hum Reprod. 1996;2(9):679–684.
- Vlodavsky I, Beckhove P, Lerner I, et al. Significance of heparanase in cancer and inflammation. Cancer Microenviron. 2012;5(2):115–132.
- Vlodavsky I, Goldshmidt O, Zcharia E, et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol. 2002;12(2):121–129.
- Lorente-Gea L, García B, Martín C, et al. Heparan sulfate proteoglycans and heparanases in Alzheimer’s disease: current outlook and potential therapeutic targets. Neural Regen Res. 2017;12(6):914–915.
- Pisano C, Vlodavsky I, Ilan N, et al. The potential of heparanase as a therapeutic target in cancer. Biochem Pharmacol. 2014;89(1):12–19.
- Tatour M, Shapira M, Axelman E, et al. Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1. Thromb Haemost. 2017;117(7):1391–1401.
- Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase*. J Biol Chem. 2006;281(33):23804–23811.
- Dempsey LA, Plummer TB, Coombes SL, et al. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology. 2000;10(5):467–475.
- Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science. 1994;266(5190):1508–1518.
- Nadir Y, Henig I, Naroditzky I, et al. Involvement of heparanase in early pregnancy losses. Thromb Res. 2010;125(5):e251–e257.
- Ginath S, Lurie S, Golan A, et al. The expression of heparanase in normal and preeclamptic placentas. J Matern Fetal Neonatal Med. 2015;28(13):1589–1593.
- Famá EAB, Souza RS, Melo CM, et al. Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia. Clin Chim Acta. 2014;437:155–160.
- Nadir Y, Kenig Y, Drugan A, et al. Involvement of heparanase in vaginal and cesarean section deliveries. Thromb Res. 2010;126(6):e444–e450.
- Haimov-Kochman R, Friedmann Y, Prus D, et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod. 2002;8(6):566–573.
- Martin JA, Hamilton BE, Osterman MJ, et al. Births: final data for 2013. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2015;64:1–65.
- Romero R, Espinoza J, Kusanovic J, et al. The preterm parturition syndrome. BJOG Int J Obstet Gynaecol. 2006;113:17–42.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
- Nelson DM, Burton GJ. A technical note to improve the reporting of studies of the human placenta. Placenta. 2011;32(2):195–196.
- Yagel S. Angiogenesis in gestational vascular complications. Thromb Res. 2011;127:S64–S66.
- Eddy AC, Chapman H, George EM. Heparanase regulation of sFLT-1 release in trophoblasts in vitro. Placenta. 2019;85:63–68.
- Che G, Wang Y, Zhou B, et al. Knockdown of heparanase suppresses invasion of human trophoblasts by activating p38 MAPK signaling pathway. Dis Markers. 2018;2018:7413027.
- Nadir Y, Brenner B. Heparanase—a link between coagulation, angiogenesis, and cancer. rambam maimonides. Med J. 2012;3(1):e0002.
- Nadir Y, Brenner B, Zetser A, et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost. 2006;4(11):2443–2451.
- Wu W, Pan C, Meng K, et al. Hypoxia activates heparanase expression in an NF-kappaB dependent manner. Oncol Rep. 2010;23:255–261.